Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Are These Warren Buffett Stocks Still Outperforming the S&P 500 and Worth Buying?

Reading Time: < 1 minute

Warren Buffett, the legendary investor, continues to showcase his winning ways in 2024 with three of his stocks outperforming the S&P 500.

First up is Nu Holdings (NYSE: NOW), a fintech stock that has surged over 40% year to date, leaving the S&P 500’s 12% gain in the dust. Despite initial struggles after its IPO in 2021, Nu has seen a remarkable turnaround and operates one of the largest digital banks in Brazil, Colombia, and Mexico.

Next is DaVita (NYSE: DVA), a dialysis services provider that has seen a 38% return so far this year. While not a subsidiary of Berkshire Hathaway, Buffett’s conglomerate owns a significant 41.2% stake in the company. DaVita’s earnings doubled in the first quarter of 2024, driven by a cyber attack on Change Healthcare.

Lastly, Mitsui (OTC: MITSF) has been the best performer among Buffett’s five Japanese stocks, with a 31% gain in 2024. Buffett has praised Mitsui for its shareholder-friendly policies and listed it as one of the eight stocks Berkshire expects to own indefinitely.

While these stocks have delivered impressive returns, investors should carefully consider their investment decisions. Nu may appeal to growth investors, Mitsui to value investors, and DaVita for its steady business expansion.

In conclusion, Buffett’s winning streak continues with these three stocks, but investors should conduct thorough research before making any investment decisions.

Taylor Swifts New Album Release Health issues from using ACs Boston Marathon 2024 15 Practical Ways To Save Money